BIOMAT Database Logo BIOMAT Database Logo

Quinine clearance during continuous veno-venous high-volume hemofiltration. 2008

Jérôme Liotier, and Damien Richard, and Patrice Deteix, and François Coudoré, and Bertrand Souweine

UI MeSH Term Description Entries
D008297 Male Males
D011803 Quinine An alkaloid derived from the bark of the cinchona tree. It is used as an antimalarial drug, and is the active ingredient in extracts of the cinchona that have been used for that purpose since before 1633. Quinine is also a mild antipyretic and analgesic and has been used in common cold preparations for that purpose. It was used commonly and as a bitter and flavoring agent, and is still useful for the treatment of babesiosis. Quinine is also useful in some muscular disorders, especially nocturnal leg cramps and myotonia congenita, because of its direct effects on muscle membrane and sodium channels. The mechanisms of its antimalarial effects are not well understood. Biquinate,Legatrim,Myoquin,Quinamm,Quinbisan,Quinbisul,Quindan,Quinimax,Quinine Bisulfate,Quinine Hydrochloride,Quinine Lafran,Quinine Sulfate,Quinine Sulphate,Quinine-Odan,Quinoctal,Quinson,Quinsul,Strema,Surquina,Bisulfate, Quinine,Hydrochloride, Quinine,Sulfate, Quinine,Sulphate, Quinine
D006440 Hemofiltration Extracorporeal ULTRAFILTRATION technique without HEMODIALYSIS for treatment of fluid overload and electrolyte disturbances affecting renal, cardiac, or pulmonary function. Arteriovenous Hemofiltration,Venovenous Hemofiltration,Arteriovenous Hemofiltrations,Hemofiltration, Arteriovenous,Hemofiltration, Venovenous,Hemofiltrations,Venovenous Hemofiltrations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000962 Antimalarials Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) Anti-Malarial,Antimalarial,Antimalarial Agent,Antimalarial Drug,Anti-Malarials,Antimalarial Agents,Antimalarial Drugs,Agent, Antimalarial,Agents, Antimalarial,Anti Malarial,Anti Malarials,Drug, Antimalarial,Drugs, Antimalarial
D012772 Shock, Septic Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status. Endotoxin Shock,Septic Shock,Shock, Endotoxic,Shock, Toxic,Toxic Shock,Toxic Shock Syndrome,Endotoxin Shocks,Shock Syndrome, Toxic,Shock, Endotoxin,Shocks, Endotoxin,Toxic Shock Syndromes
D016778 Malaria, Falciparum Malaria caused by PLASMODIUM FALCIPARUM. This is the severest form of malaria and is associated with the highest levels of parasites in the blood. This disease is characterized by irregularly recurring febrile paroxysms that in extreme cases occur with acute cerebral, renal, or gastrointestinal manifestations. Plasmodium falciparum Malaria,Malaria, Plasmodium falciparum

Related Publications

Jérôme Liotier, and Damien Richard, and Patrice Deteix, and François Coudoré, and Bertrand Souweine
Myoglobin clearance during continuous veno-venous hemofiltration with or without dialysis.
April 1998, The International journal of artificial organs,
Jérôme Liotier, and Damien Richard, and Patrice Deteix, and François Coudoré, and Bertrand Souweine
[Continuous arterio-venous hemofiltration and continuous veno-venous hemofiltration].
December 1991, Nihon rinsho. Japanese journal of clinical medicine,
Jérôme Liotier, and Damien Richard, and Patrice Deteix, and François Coudoré, and Bertrand Souweine
Amikacin pharmacokinetics during continuous veno-venous hemofiltration.
April 1991, Critical care medicine,
Jérôme Liotier, and Damien Richard, and Patrice Deteix, and François Coudoré, and Bertrand Souweine
Quinine clearance in continuous venovenous hemofiltration.
May 1996, The Annals of pharmacotherapy,
Jérôme Liotier, and Damien Richard, and Patrice Deteix, and François Coudoré, and Bertrand Souweine
Continuous Veno-Venous Hemofiltration During Intercontinental Aeromedical Evacuation.
March 2018, Military medicine,
Jérôme Liotier, and Damien Richard, and Patrice Deteix, and François Coudoré, and Bertrand Souweine
Pharmacokinetics of levofloxacin during continuous veno-venous hemofiltration.
February 2001, Intensive care medicine,
Jérôme Liotier, and Damien Richard, and Patrice Deteix, and François Coudoré, and Bertrand Souweine
Pharmacokinetics of amikacin during continuous veno-venous hemofiltration.
June 1990, Critical care medicine,
Jérôme Liotier, and Damien Richard, and Patrice Deteix, and François Coudoré, and Bertrand Souweine
Plasma concentrations and clearance of procalcitonin during continuous veno-venous hemofiltration in septic patients.
March 2001, Shock (Augusta, Ga.),
Jérôme Liotier, and Damien Richard, and Patrice Deteix, and François Coudoré, and Bertrand Souweine
Combined veno-venous bypass and high volume hemofiltration during orthotopic liver transplantation.
January 1993, ASAIO journal (American Society for Artificial Internal Organs : 1992),
Jérôme Liotier, and Damien Richard, and Patrice Deteix, and François Coudoré, and Bertrand Souweine
Heparin clearance during continuous veno-venous haemofiltration.
January 1994, Intensive care medicine,
Copied contents to your clipboard!